Clinical Trials Logo

Clinical Trial Summary

This is a multi-center evaluation of efruxifermin (EFX) in a randomized, double-blind, placebo-controlled study in cirrhotic subjects with biopsy-proven F4 compensated NASH.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms

  • Fatty Liver
  • NASH - Nonalcoholic Steatohepatitis
  • Non-alcoholic Fatty Liver Disease

NCT number NCT05039450
Study type Interventional
Source Akero Therapeutics, Inc
Contact Akero Study Director
Phone 650-487-6488
Email [email protected]
Status Recruiting
Phase Phase 2
Start date July 30, 2021
Completion date April 2024

See also
  Status Clinical Trial Phase
Not yet recruiting NCT05045534 - The Purpose of This Study is to Determine Whether TB-840 is Effective in the Treatment of Subjects With Non-alcoholic Steatohepatitis (NASH) Phase 1
Completed NCT03289897 - Non-invasive Rapid Assessment of NAFLD Using Magnetic Resonance Imaging With LiverMultiScan N/A
Not yet recruiting NCT04976283 - Effect of Oral Anti-diabetic Medication on Liver Fat in Subjects With Type II Diabetes and Non-alcoholic Fatty Liver Phase 4
Completed NCT02784444 - A Study to Evaluate the Safety, Tolerability & Efficacy of MSDC-0602K in Patients With NASH Phase 2
Recruiting NCT04321343 - Study of PXL065 in Patients With Nonalcoholic Steatohepatitis (NASH) Phase 2
Recruiting NCT04371042 - PROtocol of Metabolic and Cryptogenic livEr Disease regisTry for intEgration of Omic Studies
Not yet recruiting NCT03648554 - Researching an Effect of GLP-1 Agonist on Liver STeatosis (REALIST) Phase 4
Completed NCT03748628 - Absorption, Metabolism and Excretion (AME) Study of [14C]EDP-305 in Healthy Male Subjects Phase 1
Recruiting NCT04643795 - Phase 1 Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Multiple Oral Doses of MGL-3196 in Subjects With Varying Degrees of Hepatic Impairment and Healthy Matched Control Subjects Phase 1
Not yet recruiting NCT04232566 - Investigating the Link Between Type 2 Immunity and NAFLD in Human Obesity- AIM 2 N/A
Not yet recruiting NCT05023044 - Nonalcoholic Fatty Liver Disease in HIV Database
Recruiting NCT04109742 - Curcumin for Pediatric Nonalcoholic Fatty Liver Disease Phase 2
Not yet recruiting NCT04781933 - Interest in "Combo" (a Combination of Dietary Supplements Including Probiotics) in NASH Improvement N/A
Recruiting NCT04066400 - Role of a Wheat Containing Diet on Non-alcoholic Steatohepatitis Phase 2
Completed NCT03536650 - Effect of DMR in the Treatment of NASH N/A
Completed NCT03783897 - A Drug-drug Interaction Study to Investigate the Effect of Coadministration of EDP-305 on the PK of a Combined Oral Contraceptive in Healthy Female Subjects Phase 1
Recruiting NCT04618744 - A Study to Assess the Safety and Efficacy of Oral Insulin in T2DM Patients With Nonalcoholic Steatohepatitis (NASH) Phase 2
Active, not recruiting NCT04653103 - NASH in Subjects With Different Classes of Obesity
Recruiting NCT04173065 - A Study to Assess the Efficacy and Safety of VK2809 for 52 Weeks in Subjects With Biopsy Proven NASH Phase 2
Enrolling by invitation NCT04685993 - A Study of the Safety and Tolerability of LPCN 1144 in Subjects Who Completed the LPCN 1144-18-002 Trial Phase 2